Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Navidea Biopharmaceuticals Inc (NAVB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.0375 +0.0007    +1.90%
- Closed. Currency in USD ( Disclaimer )
After Hours
0.0375
0.0000
0.0000%
- Delayed Data
Type:  Equity
Market:  United States
  • Volume: 2,138
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.0368 - 0.0375
Navidea Biopharma 0.0375 +0.0007 +1.90%

Navidea Biopharmaceuticals Inc Company Profile

 
Get an in-depth profile of Navidea Biopharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

13

Equity Type

ORD

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates in two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (PET), gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. It develops NAV3-31, which has completed Phase IIb clinical trials for evaluating imaging repeatability, reproducibility, and stability, as well as the capacity of Tc99m tilmanocept imaging for treatment of anti-tumor necrosis factor alpha therapy in patients with moderate to severe rheumatoid arthritis (RA); NAV3-35 that is in a Phase IIb clinical trial for RA imaging; NAV3-33, which is in Phase III clinical trial for RA; and NAV3-32, which is Phase 2b trial for RA-involved joints. The company is also developing Tc99m tilmanocept for cardiovascular, kaposi’s sarcoma, tuberculosis, and other immunotherapeutic applications. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was incorporated in 1983 and is headquartered in Dublin, Ohio.

Contact Information

Address 4995 Bradenton Avenue Suite 240
Dublin, 43017-3552
United States
Phone 614 793 7500
Fax 614 793 7520

Top Executives

Name Age Since Title
Claudine E. Bruck 66 2018 Independent Director
Jed A. Latkin 47 2016 CEO, COO, CFO & Director
Sarah Kathryn Rouan 59 2018 Independent Chairman of the Board
John K. Scott 68 2021 Vice Chairman
Charles Mills - - Member of Scientific Advisory Board
Siamon Gordon - - Member of Scientific Advisory Board
Jill Bieker Stefanelli - 2023 Independent Director
Dana J. Moss 46 2023 Independent Director
Joshua M. Wilson 46 2022 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NAVB Comments

Write your thoughts about Navidea Biopharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Kay Pee
Kay Pee May 29, 2020 11:33AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wonder if this will hit $3 today.
Anwar zein
Anwar zein May 27, 2020 5:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
rise and shine
Kay Pee
Kay Pee May 26, 2020 9:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This is a big day for Navidea, let's see if the momentum continues to go upwards.
SS SS
SS SS May 24, 2020 4:00PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is a kind of joke ? what happens here ?
Oliver Steen
Oliver Steen May 24, 2020 9:41AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Do u think it will go up tuesday?
Ashraf Azeem
Ashraf Azeem May 22, 2020 2:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It will go over $3 before the end of the day
Kay Pee
Kay Pee May 22, 2020 2:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Was there any significant news on this company? Do you really think it will get to $3?
Stephen Lark
Stephen Lark Oct 31, 2018 8:57AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm Longing!!!
John Hoffman
John Hoffman May 02, 2016 9:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Recent changes suggest navb is going down and down hard.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email